AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

NUTRITIONAL GROWTH SOLUTIONS

0.017

0.000

Volume:- -

Turnover:- -

Market Cap:5.66M

PE:-0.01

High:0.017

Open:0.017

Low:0.017

Close:0.017

52wk High:0.034

52wk Low:0.017

Shares:333.09M

Float Shares:107.93M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.511

EPS(LYR):-1.511

ROE:-304.85%

ROA:-81.19%

PB:16.24

PE(LYR):-0.01

Loading ...

Overview Company News Filings

Twist Bioscience (TWST): Assessing Valuation After New Sequencing Workflow Collaboration With Element Biosciences

Simply Wall St.

Gene Solutions Brings Insights on Advances in MRD and Multi-Omics Technologies to the Singapore Society of Oncology Annual Scientific Meeting 2025

How Investors Are Reacting To Twist Bioscience (TWST) Gaining Exclusive Access to Advanced Sequencing Workflow

Simply Wall St.

Gene Solutions and AMPATH Launch Advanced Genomics Laboratory in Hyderabad to Expand Access to Precision Medicine in India

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/NGS.AU/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NGS.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"NGS.AU\",,,,,undefined,":{"symbol":"NGS.AU","market":"AU","secType":"STK","nameCN":"NUTRITIONAL GROWTH SOLUTIONS","latestPrice":0.017,"timestamp":1774588320000,"preClose":0.017,"halted":0,"volume":0,"delay":0,"changeRate":0,"nameEN":"NUTRITIONAL GROWTH SOLUTIONS","floatShares":107925515,"shares":333093207,"eps":-1.5105301379811185,"marketStatus":"Market Closed","change":0,"latestTime":"03-27 16:12:00 AEDT","open":0.017,"high":0.017,"low":0.017,"amount":0,"amplitude":0,"askPrice":0.022,"askSize":30000,"bidPrice":0.017,"bidSize":74079,"shortable":3,"etf":0,"ttmEps":-1.5105301379811185,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1774825200000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.017,"openAndCloseTimeList":[[1774566000000,1774587600000]],"volumeRatio":0,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"NGS.AU","preClose":0.018,"auctionPrice":0.02,"auctionVolume":10000,"auction":3,"marketStatus":"盘后竞价","timestamp":1773896413040}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"NGS.AU\",,,,,undefined,":{"symbol":"NGS.AU","floatShares":107925515,"roa":"-81.19%","roe":"-304.85%","lyrEps":-1.51053,"shares":333093207,"dividePrice":0,"high":0.017,"amplitude":0,"preClose":0.017,"low":0.017,"week52Low":0.017,"pbRate":"16.24","psRate":"2.40","week52High":0.034,"institutionHeld":0,"latestPrice":0.017,"committee":0.423515,"eps":-1.5105301379811185,"divideRate":0,"volume":0,"delay":0,"ttmEps":-1.5105301379811185,"open":0.017,"prevYearClose":0.022,"prevWeekClose":0.022,"prevMonthClose":0.02,"prevQuarterClose":0.022,"fiveDayClose":0.022,"twentyDayClose":0.02,"sixtyDayClose":0.022},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NGS.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2024-07-25","symbol":"NGS.AU","defaultRemindTime":1721865600000,"type":"split","dateTimestamp":1721829600000,"forFactor":10,"toFactor":1,"ratio":10},{"date":"2022-07-28","symbol":"NGS.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1658966400000,"name":null,"time":"","dateTimestamp":1658930400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NGS.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NGS.AU\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2576014906","title":"Twist Bioscience (TWST): Assessing Valuation After New Sequencing Workflow Collaboration With Element Biosciences","url":"https://stock-news.laohu8.com/highlight/detail?id=2576014906","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576014906?lang=en_us&edition=fundamental","pubTime":"2025-10-18 17:26","pubTimestamp":1760779564,"startTime":"0","endTime":"0","summary":"Twist Bioscience (TWST) has unveiled its new Trinity Freestyle Fast Hybridization workflow in collaboration with Element Biosciences, providing a streamlined sequencing solution for researchers. The expanded agreement grants Twist exclusive access to this workflow, strengthening its position in genomics.\nSee our latest analysis for Twist Bioscience.\nWhile the enhanced partnership with Element Biosciences highlights Twist Bioscience’s innovative push in genomics, the market reaction has been...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-twst/twist-bioscience/news/twist-bioscience-twst-assessing-valuation-after-new-sequenci","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-twst/twist-bioscience/news/twist-bioscience-twst-assessing-valuation-after-new-sequenci","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4585","NGS","BK4179","BK7111","TWST","NGS.AU","BK4588","BK4139"],"gpt_icon":0},{"id":"2575767330","title":"Gene Solutions Brings Insights on Advances in MRD and Multi-Omics Technologies to the Singapore Society of Oncology Annual Scientific Meeting 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2575767330","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575767330?lang=en_us&edition=fundamental","pubTime":"2025-10-16 10:30","pubTimestamp":1760581800,"startTime":"0","endTime":"0","summary":"SINGAPORE, Oct. 15, 2025 /PRNewswire/ -- What if cancer care could move from reactive to proactive?At the Singapore Society of Oncology Annual Scientific Meeting 2025 , Gene Solutions showcased how Molecular Residual Disease  and AI-powered multi-omics technologies are advancing precision oncology across Asia-Pacific, reinforcing Singapore's role as a hub for innovation and global collaboration.The symposium, \"Advancing Precision Oncology: MRD and Multi-Omics in Solid Tumors,\" gathered leading oncologists and molecular biology experts to explore how ctDNA-MRD and multi-omics support clinicians and researchers in Singapore and across the Asia-Pacific.MRD assays analyze circulating tumor DNA  in the blood to monitor cancer at the molecular level. Experts discussed how this approach may:. Unlike single-modality tests, Gene Solutions' platform integrates DNA, RNA, and AI-enhanced multi-omics signals for comprehensive tumor profiling and personalized ctDNA monitoring. This multi-omics appro","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/gene-solutions-brings-insights-on-advances-in-mrd-and-multi-omics-technologies-to-the-singapore-society-of-oncology-annual-scientific-meeting-2025-302585716.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRD.AU","NGS","BK4179","NGS.AU","BK7095","BK7111"],"gpt_icon":0},{"id":"2575473303","title":"How Investors Are Reacting To Twist Bioscience (TWST) Gaining Exclusive Access to Advanced Sequencing Workflow","url":"https://stock-news.laohu8.com/highlight/detail?id=2575473303","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575473303?lang=en_us&edition=fundamental","pubTime":"2025-10-15 19:23","pubTimestamp":1760527387,"startTime":"0","endTime":"0","summary":"On October 6, 2025, Element Biosciences and Twist Bioscience announced the launch of the new Trinity Freestyle Fast Hybridization workflow for Element’s AVITI sequencing platforms, providing a rapid, scalable, and user-friendly solution for genomic researchers.\nThis expanded agreement gives Twist Bioscience exclusive access to the workflow with its entire lineup of library preparation kits, potentially enhancing compatibility and reinforcing the appeal of Twist’s synthetic DNA technology to...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-twst/twist-bioscience/news/how-investors-are-reacting-to-twist-bioscience-twst-gaining","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-twst/twist-bioscience/news/how-investors-are-reacting-to-twist-bioscience-twst-gaining","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","BK4179","ISBC","NGS.AU","TWST","BK4588","BK4211","BK4585","BK7111","NGS"],"gpt_icon":0},{"id":"2572536201","title":"Gene Solutions and AMPATH Launch Advanced Genomics Laboratory in Hyderabad to Expand Access to Precision Medicine in India","url":"https://stock-news.laohu8.com/highlight/detail?id=2572536201","media":"prnewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572536201?lang=en_us&edition=fundamental","pubTime":"2025-10-01 20:01","pubTimestamp":1759320060,"startTime":"0","endTime":"0","summary":"HYDERABAD, India, Oct. 1, 2025 /PRNewswire/ -- Gene Solutions, a leading genetic testing innovator in Asia, has partneredwith AMPATH , a trusted provider of high-quality diagnostic services in India, to open a new advanced genomics laboratory in Hyderabad. This collaboration aimsto bring high-value, next-generation sequencing  technologies closer to patients and healthcare providers across the country.Dr. Nguyen Hoai Nghia, Co-founder and CEO of Gene Solutions , and Dr. Maneesh Bagai, COO of AMPATH , exchange the signed Memorandum of Understanding .By combining AMPATH's extensive diagnostic network with Gene Solutions' expertise in genomics, the partnership will enable more timely, accessible, and informative testing in key areas such as reproductive health, cancer screening, and personalized medicine.Supporting Better Patient Care Through Advanced Testing The collaboration between Gene Solutions and Ampath introduces advanced diagnostic tools that support more informed clinical decisi","market":"nz","thumbnail":"https://mma.prnewswire.com/media/2786650/Dr_Nguyen_Hoai_Nghia_Co_founder_CEO_Gene_Solutions__sixth_left.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2786650/Dr_Nguyen_Hoai_Nghia_Co_founder_CEO_Gene_Solutions__sixth_left.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/gene-solutions-and-ampath-launch-advanced-genomics-laboratory-in-hyderabad-to-expand-access-to-precision-medicine-in-india-302572384.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NGS.AU","BK4179","BK7111","BK6522","BLZ.SI","BK6088","MNDmain","NGS"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":24,"code":"91000000","status":"200"}]}}